Clinical trial
A Study Of The Effect Of CE-224535 On Knee OA (Osteoarthritis) Pain
NCT00418782 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00418782 |
|---|---|
| Title | A Study Of The Effect Of CE-224535 On Knee OA (Osteoarthritis) Pain |
| Official title | A 2 Week, Randomized, Double Blind, Placebo And Positive Controlled, Parallel Group, Multicenter Study Of CE-224,535 In Subjects With Osteoarthritic Pain Of The Knee |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | naproxen, CE-224535, placebo |
| Enrollment | 212 |
| Start date | Jan 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jan 5, 2007 |
| Last update posted | Dec 5, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: